BG107203A - Състав с активиращо действие - Google Patents

Състав с активиращо действие Download PDF

Info

Publication number: BG107203A
Authority: BG; Bulgaria
Prior art keywords: hematopoietic; defibrotide; csf; activating; progenitor cells
Prior art date: 2000-04-18

Application number

BG107203A

Other languages

Bulgarian (bg)

English (en)

Inventor

Laura Ferro

Roberto Porta

Massimo Iacobelli

Alessandro GIANNI

Carmelo STELLA

Original Assignee

Gentium Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-18

Filing date

2002-10-17

Publication date

2003-05-30

2002-10-17 Application filed by Gentium Spa filed Critical Gentium Spa

2003-05-30 Publication of BG107203A publication Critical patent/BG107203A/bg

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Hematology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

BG107203A 2000-04-18 2002-10-17 Състав с активиращо действие BG107203A (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00830293A EP1147777A1 (en)	2000-04-18	2000-04-18	Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
PCT/EP2001/004105 WO2001078761A2 (en)	2000-04-18	2001-04-10	Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (1)

Publication Number	Publication Date
BG107203A true BG107203A (bg)	2003-05-30

Family

ID=8175292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG107203A BG107203A (bg)	2000-04-18	2002-10-17	Състав с активиращо действие

Country Status (31)

Country	Link
US (1)	US20040131588A1 (el)
EP (3)	EP1147777A1 (el)
JP (1)	JP5205668B2 (el)
KR (1)	KR100849491B1 (el)
CN (1)	CN1183962C (el)
AT (2)	ATE310532T1 (el)
AU (2)	AU5832201A (el)
BG (1)	BG107203A (el)
CA (1)	CA2406179C (el)
CY (1)	CY1104971T1 (el)
CZ (1)	CZ20023426A3 (el)
DE (2)	DE60115222T2 (el)
DK (2)	DK1621207T3 (el)
EE (1)	EE200200596A (el)
ES (2)	ES2252227T3 (el)
HR (1)	HRP20020835A2 (el)
HU (1)	HUP0300560A3 (el)
IL (1)	IL152328A (el)
IS (1)	IS2171B (el)
MX (1)	MXPA02010346A (el)
NO (1)	NO20024988L (el)
NZ (1)	NZ522016A (el)
PL (1)	PL358100A1 (el)
PT (1)	PT1621207E (el)
RO (1)	RO121006B1 (el)
RU (1)	RU2248216C2 (el)
SI (1)	SI21079B (el)
SK (1)	SK14892002A3 (el)
UA (1)	UA73566C2 (el)
WO (1)	WO2001078761A2 (el)
ZA (1)	ZA200208413B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8771663B2 (en)	2000-04-18	2014-07-08	Gentium Spa	Formulation having mobilising activity
JP2007535479A (ja)	2003-08-13	2007-12-06	チルドレンズホスピタルメディカルセンター	ＧＴＰａｓｅを調節するためのキメラペプチド
EP1656156A2 (en)	2003-08-13	2006-05-17	Children's Hospital Medical Center	Mobilization of hematopoietic cells
EP2103689A1 (en) *	2008-03-19	2009-09-23	Gentium S.p.A.	Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
RU2376985C1 (ru) *	2008-07-17	2009-12-27	Владислав Николаевич Ласкавый	Средство для активации стволовых клеток
CN107007617A (zh)	2010-11-12	2017-08-04	真蒂奥姆责任有限公司	去纤维蛋白多核苷酸用于预防和/或治疗移植物抗宿主病(gvhd)
CN104619857A (zh)	2012-06-22	2015-05-13	真蒂奥姆有限公司	用于测定去纤维蛋白多核苷酸的生物活性的基于优球蛋白的方法
EP3026122A1 (en)	2014-11-27	2016-06-01	Gentium S.p.A.	Cellular-based method for determining the potency of defibrotide
CN106567694A (zh) *	2016-11-14	2017-04-19	北京国泰通源技术有限公司	智能控水短节
RU2758487C2 (ru) *	2018-01-12	2021-10-28	Селлмиг Биолабс Инк.	Способы получения цитокапсул и цитокапсулярных трубок
JP7270762B2 (ja)	2019-11-13	2023-05-10	富士フイルム株式会社	加飾フィルム、成型物、及び電子デバイス

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2154279A1 (de)	1970-11-03	1972-05-25	Crinos Industria Farmaco	Medikamente für das fibrinolytische System
IT1043823B (it)	1970-11-03	1980-02-29	Prephar	Procedimento per l estrazione di acidi nucleici da organi animali
US3899481A (en)	1970-11-03	1975-08-12	Crinos Industria Farmaco	Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1206341B (it)	1984-02-16	1989-04-14	Crinos Industria Farmaco	Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en)	1985-05-28	1987-09-15	Ajax Magnethermic Corporation	Apparatus for overheating edges of skelp for the production of compression welded pipe
US5223609A (en)	1986-04-17	1993-06-29	Crinos Industria Farmacobiologica S.P.A.	Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1190313B (it)	1986-04-17	1988-02-16	Crinos Industria Farmaco	Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1223322B (it) *	1987-10-23	1990-09-19	Crinos Industria Farmaco	Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) *	1988-08-24	1999-06-21	中外製薬株式会社	抗血栓剤
IT1231509B (it) *	1989-09-07	1991-12-07	Crinos Industria Farmaco	Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) *	1991-06-07	1993-04-06	Immunex Corporation	Method for improving autologous transplantation
US5977083A (en) *	1991-08-21	1999-11-02	Burcoglu; Arsinur	Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) *	1992-01-28	2000-03-15	松下電器産業株式会社	電動調理機
JPH08127539A (ja) *	1994-10-31	1996-05-21	Ajinomoto Co Inc	ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
AU3994095A (en) *	1994-11-30	1996-06-19	Chugai Seiyaku Kabushiki Kaisha	Thrombocytotic factor
WO1998001151A1 (fr) *	1996-07-10	1998-01-15	Meiji Milk Products Co., Ltd.	Nouvelle utilisation de la famille mk comme facteur hematopoietique
AU1705599A (en) *	1997-11-26	1999-06-15	Allegheny University Of The Health Sciences	Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) *	1999-01-07	2003-06-03	Heska Corporation	Feline immunoglobulin E molecules and compositions there of

2000
- 2000-04-18 EP EP00830293A patent/EP1147777A1/en not_active Withdrawn
2001
- 2001-04-10 AT AT01931582T patent/ATE310532T1/de active
- 2001-04-10 DK DK05108424.2T patent/DK1621207T3/da active
- 2001-04-10 MX MXPA02010346A patent/MXPA02010346A/es active IP Right Grant
- 2001-04-10 SI SI200120022A patent/SI21079B/sl not_active IP Right Cessation
- 2001-04-10 PT PT05108424T patent/PT1621207E/pt unknown
- 2001-04-10 DE DE60115222T patent/DE60115222T2/de not_active Expired - Lifetime
- 2001-04-10 JP JP2001576061A patent/JP5205668B2/ja not_active Expired - Fee Related
- 2001-04-10 DK DK01931582T patent/DK1276497T3/da active
- 2001-04-10 RU RU2002130719/15A patent/RU2248216C2/ru not_active IP Right Cessation
- 2001-04-10 CZ CZ20023426A patent/CZ20023426A3/cs unknown
- 2001-04-10 AU AU5832201A patent/AU5832201A/xx active Pending
- 2001-04-10 EE EEP200200596A patent/EE200200596A/xx unknown
- 2001-04-10 ES ES01931582T patent/ES2252227T3/es not_active Expired - Lifetime
- 2001-04-10 AU AU2001258322A patent/AU2001258322B2/en not_active Ceased
- 2001-04-10 RO ROA200201305A patent/RO121006B1/ro unknown
- 2001-04-10 EP EP01931582A patent/EP1276497B1/en not_active Expired - Lifetime
- 2001-04-10 EP EP05108424A patent/EP1621207B1/en not_active Expired - Lifetime
- 2001-04-10 NZ NZ522016A patent/NZ522016A/en unknown
- 2001-04-10 HU HU0300560A patent/HUP0300560A3/hu unknown
- 2001-04-10 DE DE60140015T patent/DE60140015D1/de not_active Expired - Lifetime
- 2001-04-10 WO PCT/EP2001/004105 patent/WO2001078761A2/en active IP Right Grant
- 2001-04-10 US US10/432,741 patent/US20040131588A1/en not_active Abandoned
- 2001-04-10 AT AT05108424T patent/ATE443524T1/de active
- 2001-04-10 PL PL01358100A patent/PL358100A1/xx not_active Application Discontinuation
- 2001-04-10 KR KR1020027013967A patent/KR100849491B1/ko not_active IP Right Cessation
- 2001-04-10 CN CNB018082025A patent/CN1183962C/zh not_active Expired - Fee Related
- 2001-04-10 ES ES05108424T patent/ES2335776T3/es not_active Expired - Lifetime
- 2001-04-10 CA CA2406179A patent/CA2406179C/en not_active Expired - Fee Related
- 2001-04-10 IL IL152328A patent/IL152328A/en active IP Right Grant
- 2001-04-10 SK SK1489-2002A patent/SK14892002A3/sk unknown
- 2001-10-04 UA UA2002119177A patent/UA73566C2/uk unknown
2002
- 2002-10-14 IS IS6581A patent/IS2171B/is unknown
- 2002-10-16 NO NO20024988A patent/NO20024988L/no not_active Application Discontinuation
- 2002-10-17 BG BG107203A patent/BG107203A/bg unknown
- 2002-10-17 ZA ZA200208413A patent/ZA200208413B/en unknown
- 2002-10-18 HR HR20020835A patent/HRP20020835A2/xx not_active Application Discontinuation
2006
- 2006-02-08 CY CY20061100179T patent/CY1104971T1/el unknown

Also Published As

Publication number	Publication date
NO20024988L (no)	2002-12-02
SK14892002A3 (sk)	2003-06-03
ES2335776T3 (es)	2010-04-05
CZ20023426A3 (cs)	2003-05-14
ZA200208413B (en)	2003-10-17
PT1621207E (pt)	2009-12-28
KR20030010603A (ko)	2003-02-05
SI21079A (sl)	2003-06-30
RU2002130719A (ru)	2004-03-27
MXPA02010346A (es)	2004-09-06
AU2001258322B2 (en)	2006-03-16
EP1276497A2 (en)	2003-01-22
SI21079B (sl)	2006-08-31
UA73566C2 (en)	2005-08-15
DE60115222D1 (de)	2005-12-29
RU2248216C2 (ru)	2005-03-20
NO20024988D0 (no)	2002-10-16
IS6581A (is)	2002-10-14
CN1434719A (zh)	2003-08-06
EP1621207A2 (en)	2006-02-01
DE60140015D1 (de)	2009-11-05
CY1104971T1 (el)	2010-03-03
EE200200596A (et)	2004-04-15
NZ522016A (en)	2004-10-29
DK1621207T3 (da)	2010-02-01
IS2171B (is)	2006-11-15
KR100849491B1 (ko)	2008-07-31
CA2406179A1 (en)	2001-10-25
HUP0300560A3 (en)	2005-07-28
IL152328A (en)	2009-12-24
EP1276497B1 (en)	2005-11-23
ES2252227T3 (es)	2006-05-16
JP5205668B2 (ja)	2013-06-05
EP1147777A1 (en)	2001-10-24
JP2004500437A (ja)	2004-01-08
US20040131588A1 (en)	2004-07-08
RO121006B1 (ro)	2006-11-30
HUP0300560A2 (hu)	2003-06-28
PL358100A1 (en)	2004-08-09
WO2001078761A2 (en)	2001-10-25
AU5832201A (en)	2001-10-30
ATE310532T1 (de)	2005-12-15
CN1183962C (zh)	2005-01-12
EP1621207B1 (en)	2009-09-23
DK1276497T3 (da)	2006-03-27
ATE443524T1 (de)	2009-10-15
HRP20020835A2 (en)	2005-10-31
WO2001078761A3 (en)	2002-01-24
DE60115222T2 (de)	2006-08-10
CA2406179C (en)	2012-03-27
IL152328A0 (en)	2003-05-29
EP1621207A3 (en)	2006-11-22

Publication	Publication Date	Title
US9782429B2 (en)	2017-10-10	Formulation having mobilizing activity
Riches	1996	Macrophage involvement in wound repair, remodeling, and fibrosis
JP4727988B2 (ja)	2011-07-20	エリスロポエチンの使用
Steward et al.	1989	Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions–a phase I dose-toxicity study
BG107203A (bg)	2003-05-30	Състав с активиращо действие
AU2001258322A1 (en)	2002-01-17	Formulation having mobilising activity
US7220407B2 (en)	2007-05-22	G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
CZ120298A3 (cs)	1998-09-16	Použití proteinu získaného z chemokinu savců
KR20190039145A (ko)	2019-04-10	대체 면역요법으로서의 il-12의 용도
JP3501801B2 (ja)	2004-03-02	組み換えコロニー刺激因子―１の使用
EP0800402A1 (en)	1997-10-15	Mobilisation of haematopoietic cells
KR101144687B1 (ko)	2012-05-25	Ｇ－ｃｓｆ 를 함유하는 선유아세포 동원제 및 창상 치료제
EP0661057A1 (en)	1995-07-05	Hematopoietic cell proliferation accelerator
CN115317473A (zh)	2022-11-11	棕榈酰化抑制剂在制备外周血造血干/祖细胞动员药物中的用途
JP2010539136A (ja)	2010-12-16	卒中発作を治療するためのｇ−ｃｓｆの使用